Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients

  • 21 Accesses

  • 9 Citations

Abstract

Recently it has been suggested that anti-dsDNA antibodies (Abs) promote tissue damage in systemic lupus erythematosus (SLE) by cross-reactivity with highly negatively charged tissue components such as heparan sulphate (HS), the major glycosaminoglycan of the glomerular basement membrane (GBM). Other authors, however, support the theory of DNA-anti-dsDNA immune complex deposition in situ. To further elucidate the possible role of HS antibodies, we developed a new ELISA system with heparan sulphate bound to solid phase. SLE patients (n=40) showed a higher reactivity against HS (mean=28.4, SD=34.3) as compared to normal donors (n=28, mean=15.2, SD=6.3) and patients with rheumatoid arthritis (n=35, mean=14.3, SD=6.4). The addition of native dsDNA or HS to SLE sera was followed by a dose-dependent reduction in anti-HS reactivity. In contrast, in an anti-dsDNA ELISA, no reduction was observed when HS was added to SLE sera. An increase in reactivity was observed when SLE sera with and without a prior incubation with dsDNA were digested with DNAse I or II. After the purification of serum samples by protein A sepharose under dissociative conditions, seven out of eight SLE patients showed an increase in anti-HS reactivity. No correlation of the anti-HS Abs was found with organ involvement or other serological parameters. We concluded, that there is evidence for a direct anti-HS Ab reactivity in SLE sera. A part of these antibodies seems to show low avidity anti-dsDNA cross-reactivity.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Koffler D, Schur PH, Kunke HG (1967) Immunological studies concerning the nephritis of SLE. J Exp Med 126:607–624

  2. 2.

    Stollar DB (1978) Nucleic acid antigens. In: Sela M (ed) The antigens, vol 1. Academic Press, New York, pp 1–85

  3. 3.

    Tan EM, Schur PH, Carr RI, Kunkel HG (1966) Deoxyribonucleic acid (DNA) and antibodies to DNA in serum of patients with SLE. J Clin Invest 45:1732–1740

  4. 4.

    Swaak AJG, SmeenkRJT (1985) Clinical differences between SLE patients in relation to the avidity of their anti-dsDNA. In: Peters M (ed) Protides of the biological fluids, vol 33. Pergamon Press, New York, pp 317–320

  5. 5.

    Bernstein RM, Hobbs RN, Lea DJ, Ward DJ, Hughes GRV (1985) Patterns of anti-histone antibody specificity in systemic rheumatic disease, primary sicca syndrome and rheumatoid arthritis with vasculitis. Arthritis Rheum 28:285–289

  6. 6.

    Gripenberg M, Helve T, Kurki P (1985) Profiles of antibodies to histones, DNA and IgG in patients with systemic rheumatic diseases detemined by ELISA. J Rheumatol 12:934–941

  7. 7.

    Koffler D, Agnello V, Thoburn R, Kunkel HG (1971) SLE prototype of immune complex nephritis in man. J Exp Med [Suppl] 134:169–179

  8. 8.

    Eilat D (1985) Crossreactions of anti-DNA-Ab and the central dogma of lupus nephritis. Immunol Today 6:123–127

  9. 9.

    Faaber P, Capel PJA, Rijke GPM, Vier Winden G, v d Putte LBA, Koene RAP (1984) Crossreactivity of anti-DNA-antibodies with proteoglycans. Clin Exp Immunol 55:502–508

  10. 10.

    Faaber P, Rijke GMP, vd Putte LBA, Capel PJA, Berden JHM (1986) Crossreactivity of human and murine anti-DNA-antibodies with heparan sulphate, the major glycos-aminoglycan in glomerular basement membranes. J Clin Invest 77:1824–1830

  11. 11.

    Madaio MP, Carlson J, Cataldo J, Ucci A, Miglioreni P, Pankewycz O (1987) Murine monoclonal anti-DNA-antibodies bind directly to glomerular antigens and form immune deposits. J Immunol 138:2883–2890

  12. 12.

    Raz E, Brezis M, Rosenmann E, Eilat D (1989) Anti-DNA-antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol 142: 3076–3081

  13. 13.

    Sabbaga J, Peres LSR, Potocnjak P, Madaio MP (1989) A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the GBM. Eur J Immunol 19:137–144

  14. 14.

    Fraquhar MG, Courtoy PJ, Leukins MC, Kanwar YS (1982) Current knowledge of the functional architecture of the glomerular basement membrane. In: Kuehn K, Scoene H, Timpl R (eds) New trends in basement membrane research. Raven Press, New York, p 9

  15. 15.

    Groggel GC, Stevenson J, Hovingh P, Linker A, Border WA (1988) Changes in heparan sulphate correlate with increased glomerular permeability. Kidney Int 33:517–525

  16. 16.

    Kanwar YS, Jakubowski ML (1983) Distribution of sulphated GAG in the glomerular basement membrane and mesangial matrix. Eur J Cell Biol 31:290–296

  17. 17.

    Termaat RM, Brinkman K, Nossent JC, Swaak AJG, Smeenk RJT, Berden JHM (1990) Anti-heparan-sulphate reactivity in sera from patients with SLE with renal or non-renal manifestations. Clin Exp Immunol 82:268–278

  18. 18.

    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield N, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of SLE. Arthritis Rheum 25:1271–1277

  19. 19.

    Winkler T, Haenschel TA, Kalies J, Baenkler HW, Skwaril F, Kalden JR (1983) Constant isotype pattern of anti-DNA antibodies in patients with systemic lupus erythematosus. Clin Exp Immunol 72:434–439

  20. 20.

    Emlen W, Pisetski DS, Taylor RP (1986) Antibodies to DNA, a perspective. Arthritis Rheum 29:1417–1426

  21. 21.

    Lafter EM, Rauch J, Andrzejewski G, Stollar BD, Schwartz RS (1981) Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med 153: 897–909

  22. 22.

    Shoenfeld Y, Rauch J, Massicotte M, Stollar BD, Schwartz RS (1983) Polyspecificity of monoclonal lupus autoantibody produced by human-human hybridomas. N Engl J Med 308:414–420

  23. 23.

    Smeenk RJT, Brinkman K, v d Brink HG, Westgeest AA (1988) Reaction patterns of monoclonal antibodies to DNA. J Immunol 140:3786–3792

  24. 24.

    Cotran RS, Reinke HG (1983) Anionic sites and the mechanisms of proteinuria. N Engl J Med 309:1050–1057

  25. 25.

    Aotsuka S, Okawa-Takatsuji M, Kinoshita M, Yokohari R (1988) Analysis of negatively charged dye-binding antibodies reactive with double stranded DNA and HS in serum from patients with rheumatic diseases. Clin Exp Immunol 73:436–447

  26. 26.

    Fillit H, Shridhar PD, John DG, Valin C, Poon-King T, Zabriskie J (1985) Sera from patients with post-streptococcal glomerulonephritis contain antibodies to glomerular HS-PG. J Exp Med 161:277–289

  27. 27.

    Schmiedeke TJM, Stöckl FW, Weber R, Sugisaki Y, Batsford SR, Vogt A (1989) Histones have high affinity for the GBM. J Exp Med 169:1879–1894

  28. 28.

    Suzuki N, Harada T, Mizushima Y, Sakane T (1993) Possible pathogenetic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus. J Immunol 151:1128–1136

  29. 29.

    Smeenk RJT, Lucassen WAM, Swaak TJG (1987) Is anti-cardiolipin activity a cross-reaction of anti-DNA or a separate entity. Arthritis Rheum 30:607–617

  30. 30.

    Brinkman K, Termaat RM d Jong J, v d Brink HG, Berden JHM, Smeenk RJT (1989) Crossreactive binding patterns of monoclonal antibodies to DNA are often caused by DNA/anti-DNA immune complexes. Res Immunol 140:595–612

  31. 31.

    Ehrenstein M, Longhurst C, Isenberg DA (1993) Production and analysis of IgG monoclonal anti-DNA antibodies from systemic lupus erythematosis (SLE) patients. Clin Exp Immunol 92:39–45

  32. 32.

    Hylkema MN, Lagemaat R van de, Kramers C, Swaak AJG, Berden JHM, Smeenk RJT (1993) Anti-heparan sulphate reactivity in relation to lupus nephritis. Second European Conference on SLE, Erlangen abstract no 26

  33. 33.

    Kramers C, Termaat RM, ter Borg EJ, Berden JH (1993) Higher anti-heparan sulphate reactivity during systemic lupus erythematosus disease exacerbations with renal manifestations, a long term prospective analysis. Clin Exp Immunol 93:34–38

Download references

Author information

Correspondence to K. Pirner.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pirner, K., Rascu, A., Nürnberg, W. et al. Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients. Rheumatol Int 14, 169–174 (1994). https://doi.org/10.1007/BF00579703

Download citation

Key words

  • Systemic lupus erythematosus
  • Lupus nephritis
  • Heparan sulphate
  • Antibodies